Price Wealth’s Allergan plc AGN Stock Holding History

Price Wealth’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-49	Closed	-$9K	–	596
2020 Q1	$9K	Buy	49 +27	+123%	+$5.08K	﹤0.01%	162
2019 Q4	$4K	Buy	+22	New	+$3.97K	﹤0.01%	205
2018 Q3	–	Sell	-123	Closed	-$21K	–	468
2018 Q2	$21K	Buy	123 +24	+24%	+$3.85K	0.01%	197
2018 Q1	$17K	Buy	99 +5	+5%	+$839	0.01%	117
2017 Q4	$15K	Buy	+94	New	+$16.9K	0.01%	145

Other funds holding AGN

Ashburton (Jersey) St Helier, Jersey $227M AUM

Cerebellum San Francisco, California $21.5M AUM

Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return

JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return

VFA

Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return

OPS

Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Price Wealth's AGN Position: Q2 2020 in Review

Price Wealth sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 49 shares — an estimated $9K sold.

Price Wealth first reported a position in AGN in Q4 2017 and held it in 5 quarters. The position peaked at $21K in Q2 2018. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

Price Wealth reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
Price Wealth sold 49 Allergan plc shares in Q2 2020, an estimated $9K.
Price Wealth first reported a position in Allergan plc in Q4 2017 and held it in 5 quarters.
Price Wealth's Allergan plc position peaked at $21K in Q2 2018.
7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Price Wealth's 13F filing for Q2 2020, filed 21 Jul 2020.